MED-323, a tri-methyl endblocked polydimethylsiloxane, may be considered as an excipient for cosmetic and pharmaceutical applications and offers excellent water repellency in topical skin and hair care products. It meets the requirements of the United States Pharmacopeia National Formulary (NF) and European Pharmacopeia (EP) for a dimethicone at 350 cSt viscosity. In addition, the product is produced in NuSil's FDA-registered manufacturing site.
"NuSil's acquisition of the Simethicone product line in 2004 marked the beginning of the company's commitment to the industry," said Brian Nash, vice president of Marketing and Sales. "With exemplary products, such as MED-323, NuSil Technology unwavers in its support of the pharmaceutical industry."
A masterfile for MED-323 will be filed with the United States Food and Drug Administration, and customers interested in authorization to reference the masterfile should contact NuSil Technology directly. MED-323 is available in 5-gallon and 55-gallon quantities.
For more information, visit www.nusil.com or call 805-684-8780.
About NuSil Silicone Technology:
NuSil is a cutting-edge manufacturer of silicone compounds for healthcare, aerospace, electronics, photonics and other applications requiring precise, predictable, cost-effective materials performance. ISO-9001-certified since 1994, NuSil operates state-of-the-art laboratories and processing facilities in North America and Europe and provides on-site, in-person application engineering support worldwide. More information about NuSil Technology can be found at www.nusil.com.
NuSil Technology Introduces WaterResistant Dimethicone for Pharmaceutical Cosmeceutical Applications